{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:52:19Z","timestamp":1781617939030,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe illness caused by SARS-CoV-2 infection is associated with dysregulated cholesterol homeostasis. Proprotein convertase subtilisin\/kexin type 9 (PCSK9), which regulates serum cholesterol levels, is induced in the plasma of patients with severe SARS-CoV-2 infection, compared to critically ill patients with other conditions. PCSK9 is primarily expressed in the liver, which is susceptible to damage during severe illness. Sterol regulatory element-binding protein 2 (SREBP-2) regulates PCSK9 expression, and higher activity of both PCSK9 and SREBP-2 is associated with liver injury and inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Liver tissues from 20 COVID-19 and 20 pre-pandemic autopsy cases were analysed, matched for age, sex, and intensive care treatment. Hepatic PCSK9 and SREBP-2 protein levels were assessed via immunohistochemistry. Histological scores for steatosis, fibrosis, and cholestasis were recorded. Additionally, plasma SREBP-2 levels were measured by ELISA in 25 septic COVID-19 and 34 septic non-COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across all cases, hepatocellular PCSK9 protein level was increased in the presence of cholestasis and positively correlated with hepatic SREBP-2 expression. No significant differences were observed between the COVID-19 and control groups regarding liver histology or hepatic PCSK9 and SREBP-2 protein levels. Plasma SREBP-2 levels were similar between COVID-19 and non-COVID-19 septic patients. Correlation analysis revealed positive associations between plasma SREBP-2, plasma PCSK9, and cholesteryl ester levels in the entire cohort, suggesting preserved SREBP-2 function during critical illness. Laboratory measures of liver disease in patients with and without SARS-CoV-2 infection were similar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Critically ill patients with and without SARS-CoV-2 infection exhibit comparable hepatic expression of PCSK9 and SREBP-2, as well as similar liver histology and comparable levels of aminotransferases, bilirubin, and gamma-glutamyl transferase, which suggests that SARS-CoV-2 does not directly cause liver injury. As our cohort was small, this suggestion needs to be confirmed by studying larger groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12129-1","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:41:00Z","timestamp":1763059260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Profiles of PCSK9, SREBP-2, and histopathology in COVID-19 and non-COVID-19 critical illness"],"prefix":"10.1186","volume":"25","author":[{"given":"Florian","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Boor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"L\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"von Stillfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"12129_CR1","doi-asserted-by":"crossref","unstructured":"Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, Esfahani MA, Civile VT, Marusic A, Jeroncic A et al. Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med 2020;9(4).","DOI":"10.3390\/jcm9040941"},{"key":"12129_CR2","doi-asserted-by":"crossref","unstructured":"Georgieva E, Ananiev J, Yovchev Y, Arabadzhiev G, Abrashev H, Abrasheva D, Atanasov V, Kostandieva R, Mitev M, Petkova-Parlapanska K et al. COVID-19 complications: oxidative stress, inflammation, and mitochondrial and endothelial dysfunction. Int J Mol Sci 2023;24(19).","DOI":"10.3390\/ijms241914876"},{"key":"12129_CR3","doi-asserted-by":"crossref","unstructured":"Grewal T, Nguyen MKL, Buechler C. Cholesterol and COVID-19-therapeutic opportunities at the host\/virus interface during cell entry. Life Sci Alliance 2024;7(5).","DOI":"10.26508\/lsa.202302453"},{"issue":"4","key":"12129_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.202105-1197TR","volume":"205","author":"DA Hofmaenner","year":"2022","unstructured":"Hofmaenner DA, Kleyman A, Press A, Bauer M, Singer M. The many roles of cholesterol in sepsis: A review. Am J Respir Crit Care Med. 2022;205(4):388\u201396.","journal-title":"Am J Respir Crit Care Med"},{"key":"12129_CR5","doi-asserted-by":"crossref","unstructured":"Grewal T, Buechler C. Emerging insights on the diverse roles of proprotein convertase subtilisin\/kexin type 9 (PCSK9) in chronic liver diseases: cholesterol metabolism and beyond. Int J Mol Sci 2022;23(3).","DOI":"10.3390\/ijms23031070"},{"issue":"2","key":"12129_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000442976","volume":"8","author":"JH Boyd","year":"2016","unstructured":"Boyd JH, Fjell CD, Russell JA, Sirounis D, Cirstea MS, Walley KR. Increased plasma PCSK9 levels are associated with reduced endotoxin clearance and the development of acute organ failures during sepsis. J Innate Immun. 2016;8(2):211\u201320.","journal-title":"J Innate Immun"},{"issue":"6","key":"12129_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2174\/0929867328666210714160343","volume":"29","author":"L Magnasco","year":"2022","unstructured":"Magnasco L, Sepulcri C, Antonello RM, Di Bella S, Labate L, Luzzati R, Giacobbe DR, Bassetti M. The role of PCSK9 in infectious diseases. Curr Med Chem. 2022;29(6):1000\u201315.","journal-title":"Curr Med Chem"},{"key":"12129_CR8","doi-asserted-by":"crossref","unstructured":"Mester P, Amend P, Schmid S, Muller M, Buechler C, Pavel V. Plasma proprotein convertase subtilisin\/kexin type 9 (PCSK9) as a possible biomarker for severe COVID-19. Viruses 2023;15(7).","DOI":"10.3390\/v15071511"},{"key":"12129_CR9","doi-asserted-by":"crossref","unstructured":"Yuan Y, Wu W, Sun S, Zhang Y, Chen Z. PCSK9: a potential therapeutic target for sepsis. J Immunol Res 2020;2020:2687692.","DOI":"10.1155\/2020\/2687692"},{"issue":"4","key":"12129_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/idr16040045","volume":"16","author":"P Mester","year":"2024","unstructured":"Mester P, Amend P, Schmid S, Wenzel JJ, Horing M, Liebisch G, Krautbauer S, Muller M, Buechler C, Pavel V. Proprotein convertase subtilisin\/kexin type 9 induction in COVID-19 is poorly associated with disease severity and cholesterol levels. Infect Dis Rep. 2024;16(4):593\u2013607.","journal-title":"Infect Dis Rep"},{"issue":"3","key":"12129_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jacc.2022.10.030","volume":"81","author":"EP Navarese","year":"2023","unstructured":"Navarese EP, Podhajski P, Gurbel PA, Grzelakowska K, Ruscio E, Tantry U, Magielski P, Kubica A, Niezgoda P, Adamski P, et al. PCSK9 Inhibition during the inflammatory stage of SARS-CoV-2 infection. J Am Coll Cardiol. 2023;81(3):224\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"12129_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1194\/jlr.M700443-JLR200","volume":"49","author":"HJ Jeong","year":"2008","unstructured":"Jeong HJ, Lee HS, Kim KS, Kim YK, Yoon D, Park SW. Sterol-dependent regulation of proprotein convertase subtilisin\/kexin type 9 expression by sterol-regulatory element binding protein-2. J Lipid Res. 2008;49(2):399\u2013409.","journal-title":"J Lipid Res"},{"key":"12129_CR13","doi-asserted-by":"crossref","unstructured":"Grewal T, Nguyen MKL, Buechler C. Cholesterol and cholesterol-lowering medications in COVID-19-an unresolved matter. Int J Mol Sci 2024;25(19).","DOI":"10.3390\/ijms251910489"},{"key":"12129_CR14","doi-asserted-by":"crossref","unstructured":"Essalmani R, Andreo U, Evagelidis A, Le Devehat M, Pereira Ramos OH, Fruchart Gaillard C, Susan-Resiga D, Cohen EA, Seidah NG. SKI-1\/S1P Facilitates SARS-CoV-2 spike induced cell-to-cell fusion via activation of SREBP-2 and metalloproteases, whereas PCSK9 enhances the degradation of ACE2. Viruses 2023;15(2).","DOI":"10.3390\/v15020360"},{"key":"12129_CR15","doi-asserted-by":"crossref","unstructured":"Li N, Li X, Ding Y, Liu X, Diggle K, Kisseleva T, Brenner DA. SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies. Biomedicines 2023;11(12).","DOI":"10.3390\/biomedicines11123280"},{"issue":"1","key":"12129_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41392-020-00292-7","volume":"5","author":"W Lee","year":"2020","unstructured":"Lee W, Ahn JH, Park HH, Kim HN, Kim H, Yoo Y, Shin H, Hong KS, Jang JG, Park CG, et al. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther. 2020;5(1):186.","journal-title":"Signal Transduct Target Ther"},{"key":"12129_CR17","doi-asserted-by":"crossref","unstructured":"Soares VC, Dias SSG, Santos JC, Azevedo-Quintanilha IG, Moreira IBG, Sacramento CQ, Fintelman-Rodrigues N, Temerozo JR, da Silva MAN, Barreto-Vieira DF et al. Inhibition of the SREBP pathway prevents SARS-CoV-2 replication and inflammasome activation. Life Sci Alliance 2023;6(11).","DOI":"10.26508\/lsa.202302049"},{"issue":"5","key":"12129_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.immuni.2018.08.021","volume":"49","author":"C Guo","year":"2018","unstructured":"Guo C, Chi Z, Jiang D, Xu T, Yu W, Wang Z, Chen S, Zhang L, Liu Q, Guo X, et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49(5):842\u201356. e847.","journal-title":"Immunity"},{"key":"12129_CR19","doi-asserted-by":"publisher","first-page":"112158","DOI":"10.1016\/j.biopha.2021.112158","volume":"143","author":"MD Shah","year":"2021","unstructured":"Shah MD, Sumeh AS, Sheraz M, Kavitha MS, Venmathi Maran BA, Rodrigues KF. A mini-review on the impact of COVID 19 on vital organs. Biomed Pharmacother. 2021;143:112158.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"12129_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017\u201332.","journal-title":"Nat Med"},{"key":"12129_CR21","doi-asserted-by":"crossref","unstructured":"Mester P, Drosch L, Schmid S, Weber F, Kandulski A, Muller M, Pavel V. Haematemesis in an elderly patient. Gut 2025;74(9):1363\u2013513.","DOI":"10.1136\/gutjnl-2024-333198"},{"issue":"3","key":"12129_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s42255-022-00552-6","volume":"4","author":"N Wanner","year":"2022","unstructured":"Wanner N, Andrieux G, Badia IMP, Edler C, Pfefferle S, Lindenmeyer MT, Schmidt-Lauber C, Czogalla J, Wong MN, Okabayashi Y, et al. Molecular consequences of SARS-CoV-2 liver tropism. Nat Metab. 2022;4(3):310\u20139.","journal-title":"Nat Metab"},{"key":"12129_CR23","doi-asserted-by":"crossref","unstructured":"Chen S, Zhang Y, Ashuo A, Song S, Yuan L, Wang W, Wang C, Du Z, Wu Y, Tan D et al. Combination of spatial transcriptomics analysis and retrospective study reveals liver infection of SARS-COV-2 is associated with clinical outcomes of COVID-19. EBioMedicine 2024;111:105517.","DOI":"10.1016\/j.ebiom.2024.105517"},{"key":"12129_CR24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ijid.2020.12.047","volume":"103","author":"M Lubnow","year":"2021","unstructured":"Lubnow M, Schmidt B, Fleck M, Salzberger B, Muller T, Peschel G, Schneckenpointner R, Lange T, Hitzenbichler F, Kieninger M, et al. Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking wilson\u2019s disease: balancing immunosuppression. Int J Infect Dis. 2021;103:624\u20137.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"12129_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/hep4.1820","volume":"6","author":"MF Santana","year":"2022","unstructured":"Santana MF, Guerra MT, Hundt MA, Ciarleglio MM, Pinto RAA, Dutra BG, Xavier MS, Lacerda MVG, Ferreira AJ, Wanderley DC, et al. Correlation between clinical and pathological findings of liver injury in 27 patients with lethal COVID-19 infections in Brazil. Hepatol Commun. 2022;6(2):270\u201380.","journal-title":"Hepatol Commun"},{"key":"12129_CR26","doi-asserted-by":"publisher","first-page":"103104","DOI":"10.1016\/j.ebiom.2020.103104","volume":"61","author":"R Bussani","year":"2020","unstructured":"Bussani R, Schneider E, Zentilin L, Collesi C, Ali H, Braga L, Volpe MC, Colliva A, Zanconati F, Berlot G, et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine. 2020;61:103104.","journal-title":"EBioMedicine"},{"issue":"2","key":"12129_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s11357-022-00700-6","volume":"45","author":"A Pesti","year":"2023","unstructured":"Pesti A, Danics K, Glasz T, Varkonyi T, Barbai T, Reszegi A, Kovalszky I, Valyi-Nagy I, Dobi D, Lotz G, et al. Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies. Geroscience. 2023;45(2):1015\u201331.","journal-title":"Geroscience"},{"key":"12129_CR28","doi-asserted-by":"publisher","first-page":"123022","DOI":"10.1016\/j.lfs.2024.123022","volume":"356","author":"M Vinutha","year":"2024","unstructured":"Vinutha M, Sharma UR, Swamy G, Rohini S, Vada S, Janandri S, Haribabu T, Taj N, Gayathri SV, Jyotsna SK, et al. COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review. Life Sci. 2024;356:123022.","journal-title":"Life Sci"},{"issue":"3","key":"12129_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jceh.2020.03.001","volume":"10","author":"A Agarwal","year":"2020","unstructured":"Agarwal A, Chen A, Ravindran N, To C, Thuluvath PJ. Gastrointestinal and liver manifestations of COVID-19. J Clin Exp Hepatol. 2020;10(3):263\u20135.","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"12129_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.gtc.2022.09.001","volume":"52","author":"S Ekpanyapong","year":"2023","unstructured":"Ekpanyapong S, Reddy KR. Liver and biliary tract disease in patients with coronavirus disease-2019 infection. Gastroenterol Clin North Am. 2023;52(1):13\u201336.","journal-title":"Gastroenterol Clin North Am"},{"issue":"9","key":"12129_CR31","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1111\/liv.14455","volume":"40","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020;40(9):2095\u2013103.","journal-title":"Liver Int"},{"issue":"5","key":"12129_CR32","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1093\/infdis\/jiae210","volume":"230","author":"SP Selvamani","year":"2024","unstructured":"Selvamani SP, Khan A, Tay ESE, Garvey M, Ajoyan H, Diefenbach E, Gloss BS, Tu T, George J, Douglas MW. Hepatitis B virus and hepatitis C virus affect mitochondrial function through different metabolic Pathways, explaining virus-Specific clinical features of chronic hepatitis. J Infect Dis. 2024;230(5):e1012\u201322.","journal-title":"J Infect Dis"},{"issue":"4","key":"12129_CR33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","volume":"50","author":"F Caballero","year":"2009","unstructured":"Caballero F, Fernandez A, De Lacy AM, Fernandez-Checa JC, Caballeria J, Garcia-Ruiz C. Enhanced free cholesterol, SREBP-2 and star expression in human NASH. J Hepatol. 2009;50(4):789\u201396.","journal-title":"J Hepatol"},{"issue":"1","key":"12129_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10753-019-01114-x","volume":"43","author":"Y Zou","year":"2020","unstructured":"Zou Y, Li S, Xu B, Guo H, Zhang S, Cai Y. Inhibition of proprotein convertase Subtilisin\/Kexin type 9 ameliorates liver fibrosis via mitigation of intestinal endotoxemia. Inflammation. 2020;43(1):251\u201363.","journal-title":"Inflammation"},{"issue":"3","key":"12129_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.14218\/JCTH.2017.00061","volume":"6","author":"A Moslehi","year":"2018","unstructured":"Moslehi A, Hamidi-Zad Z. Role of SREBPs in liver diseases: A Mini-review. J Clin Transl Hepatol. 2018;6(3):332\u20138.","journal-title":"J Clin Transl Hepatol"},{"key":"12129_CR36","doi-asserted-by":"crossref","unstructured":"Grimm J, Peschel G, Muller M, Schacherer D, Wiest R, Weigand K, Buechler C. Rapid decline of serum proprotein convertase subtilisin\/kexin 9 (PCSK9) in non-cirrhotic patients with chronic hepatitis C infection receiving direct-acting antiviral therapy. J Clin Med 2021;10(8).","DOI":"10.3390\/jcm10081621"},{"issue":"5","key":"12129_CR37","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/idr16050062","volume":"16","author":"C Birner","year":"2024","unstructured":"Birner C, Mester P, Liebisch G, Horing M, Schmid S, Muller M, Pavel V, Buechler C. Lipid metabolism disorders as diagnostic biosignatures in sepsis. Infect Dis Rep. 2024;16(5):806\u201319.","journal-title":"Infect Dis Rep"},{"issue":"8","key":"12129_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"8","key":"12129_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762\u201374.","journal-title":"JAMA"},{"key":"12129_CR40","doi-asserted-by":"crossref","unstructured":"Chandrasekaran P, Weiskirchen R. The role of SCAP\/SREBP as central regulators of lipid metabolism in hepatic steatosis. Int J Mol Sci 2024;25(2).","DOI":"10.3390\/ijms25021109"},{"issue":"6","key":"12129_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"12129_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2021.12.040","volume":"185","author":"P Georg","year":"2022","unstructured":"Georg P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, Kostevc T, Gabel C, Schneider M, Streitz M, et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022;185(3):493\u2013512. e425.","journal-title":"Cell"},{"issue":"23","key":"12129_CR43","first-page":"2801","volume":"17","author":"C Buechler","year":"2011","unstructured":"Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol. 2011;17(23):2801\u201311.","journal-title":"World J Gastroenterol"},{"key":"12129_CR44","doi-asserted-by":"publisher","first-page":"876046","DOI":"10.3389\/fmed.2022.876046","volume":"9","author":"TS Metkus","year":"2022","unstructured":"Metkus TS, Kim BS, Jones SR, Martin SS, Schulman SP, Leucker TM. Plasma proprotein convertase Subtilisin\/kexin type 9 (PCSK9) in the acute respiratory distress syndrome. Front Med (Lausanne). 2022;9:876046.","journal-title":"Front Med (Lausanne)"},{"issue":"13","key":"12129_CR45","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.21037\/atm-21-1291","volume":"9","author":"J Yu","year":"2021","unstructured":"Yu J, Wang Y, Lin S, Jiang L, Sang L, Zheng X, Zhong M. Severe COVID-19 has a distinct phenotype from bacterial sepsis: a retrospective cohort study in deceased patients. Ann Transl Med. 2021;9(13):1054.","journal-title":"Ann Transl Med"},{"issue":"6","key":"12129_CR46","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jiph.2022.05.008","volume":"15","author":"L Heubner","year":"2022","unstructured":"Heubner L, Hattenhauer S, Guldner A, Petrick PL, Rossler M, Schmitt J, Schneider R, Held HC, Mehrholz J, Bodechtel U, et al. Characteristics and outcomes of sepsis patients with and without COVID-19. J Infect Public Health. 2022;15(6):670\u20136.","journal-title":"J Infect Public Health"},{"key":"12129_CR47","doi-asserted-by":"publisher","first-page":"737039","DOI":"10.3389\/fmolb.2021.737039","volume":"8","author":"F Schmelter","year":"2021","unstructured":"Schmelter F, Foh B, Mallagaray A, Rahmoller J, Ehlers M, Lehrian S, von Kopylow V, Kunsting I, Lixenfeld AS, Martin E, et al. Metabolic and lipidomic markers differentiate COVID-19 from Non-Hospitalized and other intensive care patients. Front Mol Biosci. 2021;8:737039.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"12129_CR48","doi-asserted-by":"publisher","first-page":"e0155030","DOI":"10.1371\/journal.pone.0155030","volume":"11","author":"E Topchiy","year":"2016","unstructured":"Topchiy E, Cirstea M, Kong HJ, Boyd JH, Wang Y, Russell JA, Walley KR. Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor. PLoS ONE. 2016;11(5):e0155030.","journal-title":"PLoS ONE"},{"issue":"12","key":"12129_CR49","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.clinthera.2024.09.021","volume":"46","author":"K Polat","year":"2024","unstructured":"Polat K, G\u00f6mleksiz M, Oral K, G\u00f6zel N, Solowski G, Kaymaz T, G\u00fcrsu MF. Correlation of triethylamine N-oxide (TMAO), LPS, and TNF-Alpha levels with clinical features of the disease in patients with and without septic shock infected with COVID-19 virus. Clin Ther. 2024;46(12):e1\u20138.","journal-title":"Clin Ther"},{"issue":"5985","key":"12129_CR50","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1126\/science.1189123","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","unstructured":"Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010;328(5985):1566\u20139.","journal-title":"Science"},{"issue":"9","key":"12129_CR51","doi-asserted-by":"publisher","first-page":"895","DOI":"10.5551\/jat.RV17012","volume":"24","author":"T Nozue","year":"2017","unstructured":"Nozue T. Lipid Lowering therapy and Circulating PCSK9 concentration. J Atheroscler Thromb. 2017;24(9):895\u2013907.","journal-title":"J Atheroscler Thromb"},{"key":"12129_CR52","doi-asserted-by":"crossref","unstructured":"Dressel A, Fath F, Kramer BK, Klose G, Marz W. Statins for primary prevention of cardiovascular disease in Germany: benefits and costs. Clin Res Cardiol 2025; online ahead of print.","DOI":"10.2139\/ssrn.4989213"},{"issue":"13","key":"12129_CR53","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.297.13.1455","volume":"297","author":"R Gupta","year":"2007","unstructured":"Gupta R, Plantinga LC, Fink NE, Melamed ML, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and sepsis events [corrected] in patients with chronic kidney disease. JAMA. 2007;297(13):1455\u201364.","journal-title":"JAMA"},{"issue":"3","key":"12129_CR54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bjid.2016.12.008","volume":"21","author":"Q Gui","year":"2017","unstructured":"Gui Q, Yang Y, Zhang J. Effects of Statins on the development of sepsis and organ dysfunction in hospitalized older patients in China. Braz J Infect Dis. 2017;21(3):255\u201362.","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"12129_CR55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13054-023-04387-9","volume":"27","author":"SM Pienkos","year":"2023","unstructured":"Pienkos SM, Moore AR, Guan J, Levitt JE, Matthay MA, Baron RM, Conlon J, McAuley DF, O\u2019Kane CM, Rogers AJ. Effect of total cholesterol and Statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials. Crit Care. 2023;27(1):126.","journal-title":"Crit Care"},{"issue":"31","key":"12129_CR56","doi-asserted-by":"publisher","first-page":"e11578","DOI":"10.1097\/MD.0000000000011578","volume":"97","author":"M Chen","year":"2018","unstructured":"Chen M, Ji M, Si X. The effects of Statin therapy on mortality in patients with sepsis: A meta-analysis of randomized trials. Med (Baltim). 2018;97(31):e11578.","journal-title":"Med (Baltim)"},{"key":"12129_CR57","doi-asserted-by":"publisher","first-page":"102455","DOI":"10.1016\/j.mib.2024.102455","volume":"79","author":"N Heinen","year":"2024","unstructured":"Heinen N, Klohn M, Westhoven S, Brown RJ, Pfaender S. Host determinants and responses underlying SARS-CoV-2 liver tropism. Curr Opin Microbiol. 2024;79:102455.","journal-title":"Curr Opin Microbiol"},{"issue":"6","key":"12129_CR58","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/jgh3.12771","volume":"6","author":"MI Ghenu","year":"2022","unstructured":"Ghenu MI, Dragos D, Manea MM, Ionescu D, Negreanu L. Pathophysiology of sepsis-induced cholestasis: A review. JGH Open. 2022;6(6):378\u201387.","journal-title":"JGH Open"},{"issue":"1","key":"12129_CR59","doi-asserted-by":"publisher","first-page":"23377","DOI":"10.1038\/s41598-024-73948-x","volume":"14","author":"M Schneeweiss-Gleixner","year":"2024","unstructured":"Schneeweiss-Gleixner M, Krenn K, Petter M, Haselwanter P, Kraft F, Adam L, Semmler G, Hartl L, Halilbasic E, Buchtele N, et al. Presence of cholestasis and its impact on survival in SARS-CoV-2 associated acute respiratory distress syndrome. Sci Rep. 2024;14(1):23377.","journal-title":"Sci Rep"},{"issue":"3","key":"12129_CR60","first-page":"246","volume":"8","author":"L Fu","year":"2020","unstructured":"Fu L, Fei J, Xu S, Xiang HX, Xiang Y, Hu B, Li MD, Liu FF, Li Y, Li XY, et al. Liver dysfunction and its association with the risk of death in COVID-19 patients: A prospective cohort study. J Clin Transl Hepato. 2020;8(3):246\u201354.","journal-title":"J Clin Transl Hepato"},{"key":"12129_CR61","doi-asserted-by":"publisher","first-page":"155774","DOI":"10.1016\/j.metabol.2023.155774","volume":"152","author":"Z Chen","year":"2024","unstructured":"Chen Z, Shao W, Li Y, Zhang X, Geng Y, Ma X, Tao B, Ma Y, Yi C, Zhang B, et al. Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPARalpha-mediated CYP7A1 activation. Metabolism. 2024;152:155774.","journal-title":"Metabolism"},{"issue":"6","key":"12129_CR62","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep4.1899","volume":"6","author":"Y Huber","year":"2022","unstructured":"Huber Y, Schulz A, Schmidtmann I, Beutel M, Pfeiffer N, Munzel T, Galle PR, Wild PS, Lackner KJ, Schattenberg JM. Prevalence and risk factors of advanced liver fibrosis in a Population-Based study in Germany. Hepatol Commun. 2022;6(6):1457\u201366.","journal-title":"Hepatol Commun"},{"issue":"1","key":"12129_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12129-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12129-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12129-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:59:21Z","timestamp":1781614761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12129-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12129"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12129-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethical committee of the University Hospital Aachen (EK 304\/20, EK 119\/20, and EK 092\/20) and of the ethical committee of the University Hospital of Regensburg (18-1029-101). The study protocol was approved by and was performed in accordance with the updated guidelines of good clinical practice and the updated Declaration of Helsinki. Informed consent for autopsy was obtained from the legal representatives of the deceased patients. Informed consent for blood samples was obtained from the patients or their legal representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1573"}}